Clinical TrialsSearch results
Number of results: 206
Recruiting
- Treatment of refractory ulcers with Simonkolleite
- refractory skin ulcer
- Norio Fukuda
- 2021-11-18
Other
- A study of oral asciminib versus other TKIs in adult patients with newly diagnosed Ph+ CML-CP
- newly diagnosed Ph+ CML-CP
- Kazuyuki Suzuki
- 2021-12-26
Other
- A Phase 3 Study to Assess Efficacy and Safety of Tafasitamab Plus Lenalidomide and Rituximab Compared to Placebo Plus Lenalidomide and Rituximab in Patients With Relapsed/Refractory (R/R) Follicular Lymphoma or Marginal Zone Lymphoma
- Follicular Lymphoma, Marginal Zone Lymphoma
- Eiji Ueda
- 2022-01-18
Other
- A Phase 3 Trial of Epcoritamab vs Investigator's Choice Chemotherapy in R/R DLBCL
- Relapsed/Refractory DLBCL, who have failed or are ineligible for HDT-ASCT
- Vindelov Signe Diness
- 2022-07-25
Recruiting
- [M22-947] Relapsed or Refractory Multiple Myeloma: Dose Escalation and Expansion of ABBV-383 in Combination with Anti-Cancer Regimens
- Multiple Myeloma
- Satomi Natsuko
- 2022-09-16
Recruiting
- A Phase 3 Study Comparing Pirtobrutinib to Ibrutinib in CLL/SLL
- Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
- Escalon Mari
- 2022-10-08
Other
- A Study to Learn About the Study Medicine (Called Maplirpacept (PF-07901801)) in Japanese With Hematologic Malignancies
- Relapsed or refractory hematologic malignancies
- Kawai Norisuke
- 2022-11-21
Recruiting
- A Study to Learn About the Effects of the Combination of Elranatamab (PF-06863135), Daratumumab, and Lenalidomide Compared With Daratumumab, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
- Multiple Myeloma
- Kawai Norisuke
- 2022-12-26
Recruiting
- A Phase 3 study of Epcoritamab in Subjects With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)
- Diffuse Large B-Cell Lymphoma (DLBCL)
- Satomi Natsuko
- 2023-02-09
Recruiting
- Efficacy and Safety Trial of Epcoritamab With or Without Lenalidomide as First Line Therapy for Subjects With Diffuse Large B-cell Lymphoma
- People must be newly diagnosed with DLBCL and anthracycline-ineligible.
- Hoehn Daniela
- 2023-07-07